Charles River Labs (CRL)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 660 |
| % of all portfolios: | 0.036% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
2 |
$1,251,686 |
| Sells |
10 |
$826,667 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 21 Feb 2025 |
FOSTER JAMES C |
Chairman, President and CEO |
20 Feb 2025 |
6,075 |
165.01 |
1,002,436 |
| 21 Feb 2025 |
GIRSHICK BIRGIT |
Corporate Executive VP & COO |
20 Feb 2025 |
1,514 |
164.63 |
249,250 |
| 21 Nov 2023 |
GIRSHICK BIRGIT |
Corporate Executive VP & COO |
20 Nov 2023 |
1,322 |
187.82 |
248,298 |
| 15 Nov 2023 |
FOSTER JAMES C |
Chairman, President and CEO |
14 Nov 2023 |
5,620 |
178.05 |
1,000,641 |
| 29 Aug 2023 |
WALLMAN RICHARD F |
Director |
24 Aug 2023 |
1,000 |
198.79 |
198,786 |
| 24 Feb 2023 |
WALLMAN RICHARD F |
Director |
23 Feb 2023 |
1,750 |
220.73 |
386,278 |
| 06 Dec 2022 |
WALLMAN RICHARD F |
Director |
02 Dec 2022 |
1,500 |
218.90 |
328,350 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock